Newsroom

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $1.10 per share, payable on March 2, 2026, to shareholders of record at the close of business on February 17, 2026. About Carlisle Companies Incorporated Carlisle Companies Incorporated is a leading supplier of innovative building envelope products and solutions for more energy efficient buildings. Through its building products businesses – Carlisle Construction Ma...

NEW YORK--(BUSINESS WIRE)--Clay, the leading AI go-to-market (GTM) development platform, today announced its second employee tender offer in nine months, giving team members the opportunity to sell a portion of their vested equity for liquidity. The tender offer values Clay at $5 billion, marking more than a 3x increase from the company’s previous tender last spring. Tender offers — and especially repeat tenders at this pace — are extremely rare in the private market. Clay believes employees sh...

SANTA PAULA, Calif.--(BUSINESS WIRE)--Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, today announced that Mark Palamountain will step down from his role as Chief Financial Officer to pursue interests outside of the Company. Greg Hamm, who has served as Corporate Controller since 2004 and as Vice President and Corporate Controller since...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the poster presentation of previously published safety data from the long-term treatment of children with Ataxia-Telangiectasia (A-T) at the British Paediatric Neurology Association 2026 Annual Meeting taking place in Glasgow, Scotland January 28-30, 2026. The obj...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, February 25, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, February 26, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results a...

DUNDALK, Ireland--(BUSINESS WIRE)--Cimpress plc (Nasdaq: CMPR) has posted on its investor relations website at ir.cimpress.com its financial results for the second quarter of fiscal year 2026, in a PDF file called "Q2 Fiscal Year 2026 Quarterly Earnings Document," along with an accompanying spreadsheet with historical financial results and operating metrics. As previously announced, Cimpress will host a public Q&A session tomorrow, Thursday, January 29, 2026 at 8:00 am ET. The live audio ev...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency. Domestic revenue increased 1.4% year-over-year. International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to dilute...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HubSpot, the customer platform for scaling businesses, announced today that it will report its fourth quarter and full year 2025 financial results after the U.S. financial markets close on Wednesday, February 11, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's fourth quarter and full year 2025 financial results and its business operations and outlook. HubSpot Fou...

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--OFG Bancorp (NYSE: OFG) today announced its Board of Directors approved a new $200 million stock repurchase authorization plan as part of OFG’s capital actions. The new plan, which is open-ended, is in addition to the previously authorized stock repurchase plan, which as of December 31, 2025 had $38.1 million available for repurchase. About OFG Bancorp Now in its 62nd year in business, OFG Bancorp is a diversified financial holding company that operates u...

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that on January 26, 2026 (Grant Date), the Compensation Committee of the Company’s Board of Directors granted an inducement award consisting of a non-qualified stock option to purchase 23,000 shares of Class A common...